Home LiteratureArticle Details
PMID: 10799867 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Phagosomes acquire nascent and recycling class II MHC molecules but primarily use nascent molecules in phagocytic antigen processing.

Journal of immunology (Baltimore, Md. : 1950) ·Vol. 164 ·No. 10 ·2000-05-15 ·Pages 5103-12

Ramachandra L, Harding CV

Abstract

Phagosomes contain class II MHC (MHC-II) and form peptide:MHC-II complexes, but the source of phagosomal MHC-II molecules is uncertain. Phagosomes may acquire nascent MHC-II or preexisting, recycling MHC-II that may be internalized from the plasma membrane. Brefeldin A (BFA) was used to deplete nascent MHC-II in murine macrophages to determine the relative contributions of nascent and recycling MHC-II molecules to phagocytic Ag processing. In addition, biotinylation of cell-surface proteins was used to assess the transport of MHC-II from the cell surface to phagosomes. BFA inhibited macrophage processing of latex bead-conjugated Ag for presentation to T cells, suggesting that nascent MHC-II molecules are important in phagocytic Ag processing. Furthermore, detection of specific peptide:MHC-II complexes in isolated phagosomes confirmed that BFA decreased formation of peptide:MHC-II complexes within phagosomes. Both flow organellometry and Western blot analysis of purified phagosomes showed that about two-thirds of phagosomal MHC-II was nascent (depleted by 3 h prior treatment with BFA) and primarily derived from intracellular sites. About one-third of phagosomal MHC-II was preexisting and primarily derived from the plasma membrane. BFA had little effect on phagosomal H2-DM or the degradation of bead-associated Ag. Thus, inhibition of phagocytic Ag processing by BFA correlated with depletion of nascent MHC-II in phagosomes and occurred despite the persistent delivery of plasma membrane-derived recycling MHC-II molecules and other Ag-processing components to phagosomes. These observations suggest that phagosomal Ag processing depends primarily on nascent MHC-II molecules delivered from intracellular sites, e.g., endocytic compartments.

MeSH Terms
Animals Antigen Presentation/drug effects Blotting, Western Brefeldin A/pharmacology Cell Membrane/drug effects,immunology,metabolism Drug Resistance Flow Cytometry HLA-D Antigens/biosynthesis,metabolism Histocompatibility Antigens Class II/biosynthesis,metabolism Immunosuppressive Agents/pharmacology Latex/immunology,metabolism Mice Mice, Inbred C57BL Mice, Inbred DBA Mice, Knockout Mice, Transgenic Ovalbumin/antagonists & inhibitors,immunology,metabolism Peptide Fragments/antagonists & inhibitors,immunology,metabolism Phagocytosis/drug effects Phagosomes/drug effects,immunology,metabolism
Chemicals
H2-M antigens HLA-D Antigens HLA-DM antigens Histocompatibility Antigens Class II I-Ad antigen Immunosuppressive Agents Latex OVA 323-339 Peptide Fragments Brefeldin A Ovalbumin
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Ramachandra L
Institute of Pathology, Case Western Reserve University, Cleveland, OH, 44106, USA. [email protected]
Harding C V
Article Info
Journal
Journal of immunology (Baltimore, Md. : 1950)
Abbr.
J Immunol
ISSN
0022-1767
Published
2000-05-15
Pages
5103-12
Language
English
Region
United States
NLM ID
2985117R
Subset
IM
Grants
NIAID NIH HHS · AI34343 · United States
NIAID NIH HHS · AI35726 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]